These results, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two help the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated Diseases.In response to this concern, The brand n